Selective serotonin-reuptake inhibitors and recovery after stroke

The Lancet Neurology

Volumn 10, Issue 2, 2011, Pages 110-111

  Robinson, Robert G ^a   Adams, Harold P ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; NORTRIPTYLINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

BRAIN ISCHEMIA; CONVALESCENCE; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; HEMIPARESIS; HUMAN; LETTER; PRIORITY JOURNAL; TREATMENT OUTCOME;

DEPRESSION; FLUOXETINE; HUMANS; RECOVERY OF FUNCTION; SEROTONIN UPTAKE INHIBITORS; STROKE;

EID: 78751575282     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70326-4     Document Type: Letter

References (15)

1. Chollet F, Tardy J, Albucher JF, et al. Fluoxetine in motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled tria. Lancet Neurol 2011, published online Jan 10. 10.1016/S1474-4422(10)70314-8.
2. Robinson RG The clinical neuropsychiatry of stroke 2006, Cambridge University Press, Cambridge. 2nd edn.
3. Schubert DSP, Taylor C, Lee S, Mentari A, Tamaklo W Physical consequences of depression in the stroke patient. Gen Hosp Psychiatry 1992, 14:69-76.
4. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581-1587. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
5. Parikh RM, Robinson RG, Lipsey JR, Starkstein SE, Fedoroff JP, Price TR The impact of post-stroke depression on recovery in activities of daily living over two year follow-up. Arch Neurol 1990, 47:785-789.
6. Pohjasvaara T, Vataja R, Leppavuori A, Kaste M, Erkinjuntti T Depression is an independent predictor of poor long-term functional outcome post-stroke. Eur J Neurol 2001, 8:315-319.
7. Morris PLP, Robinson RG, Andrezejewski P, Samuels J, Price TR Association of depression with 10-year post-stroke mortality. Am J Psychiatry 1993, 150:124-129.
8. House A, Knapp P, Bamford J, Vail A Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke 2001, 32:696-701.
9. Robinson RG, Jorge RE, Moser DJ, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008, 299:2391-2400.
10. Acler M, Robol E, Fiaschi A, Manganotti P A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J Neurol 2009, 256:1152-1158.
11. Manganotti P, Patuzzo S, Cortese F, Palermo A, Smania N, Fiaschi A Motor disinhibition in affected and unaffected hemisphere in the early period of recovery after stroke. Clin Neurophysiol 2002, 113:936-943.
12. Santarelli L, Saxe M, Gross C, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
13. Mikami K, Jorge RE, Adams HP Jr, et al. Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatry (in press).
14. Dam M, Tonin P, De Boni A, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996, 27:1211-1214.
15. Zittel S, Weiller C, Liepert J Citalopram improves dexterity in chronic stroke patients. Neurorehabil Neural Repair 2008, 22:311-314.